In vitro platelet activation by an echo contrast agent

Journal of Ultrasound in Medicine

Volumn 22, Issue 4, 2003, Pages 365-373

  Shigeta, Kouichirou ^a   Taniguchi, Nobuyuki ^a   Omoto, Kiyoka ^a   Madoiwa, Seiji ^a   Sakata, Yoichi ^a   Mori, Masaki ^a   Hatake, Kiyohiko ^a   Itoh, Kouichi ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

CD62P; Echo contrast agents; In vitro; Platelet activation; Ultrasound

Indexed keywords

ANTIBODIES; ANTIGENS; BLOOD;

CONTRAST AGENTS;

ULTRASONIC IMAGING;

CD61 ANTIGEN; CONTRAST MEDIUM; FLUORESCEIN ISOTHIOCYANATE; PADGEM PROTEIN; SHU 508;

ADULT; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG SAFETY; ECHOGRAPHY; HEMOSTASIS; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; NORMAL HUMAN; REACTION ANALYSIS; THROMBOCYTE ACTIVATION; TIME SERIES ANALYSIS;

EID: 0037502231     PISSN: 02784297     EISSN: None     Source Type: Journal    
DOI: 10.7863/jum.2003.22.4.365     Document Type: Article

References (34)

1. Church CC. The effects of an elastic solid surface layer on the radial pulsations of gas bubbles. J Acoust Soc Am 1995; 97:1510-1521.
2. de Jong N, Hoff L. Ultrasound scattering properties of Albunex microspheres. Ultrasonics 1993;31:175-181.
3. Holland CK, Apfel RE. Thresholds of transient cavitation produced by pulsed ultrasound in a controlled nuclei environment. J Acoust Soc Am 1990; 88:2059-2069.
4. Lotsberg O, Hovem JM, Aksum B. Experimental observation of subharmonic oscillations in Infoson bubbles. J Acoust Soc Am 1996; 99:1366-1369.
5. Crum LA, Roy RA, Dinno MA, et al. Acoustic cavitation produced by microsecond pulses of ultrasound: a discussion of some selected results. J Acoust Soc Am 1992; 91:1113-1119.
6. Williams AR, Kubowicz G, Cramer E, Schlief R. The effects of the microbubble suspension SH U 454 (Echovist) on ultrasound-induced cell lysis in a rotating tube exposure system. Echocardiography 1991; 8:423-433.
7. Carstensen EL, Kelly P, Church CC, et al. Lysis of erythrocytes by exposure to CW ultrasound. Ultrasound Med Biol 1993; 19:147-165.
8. Penney DP, Schenk EA, Maltby K, et al. Morphological effects of pulsed ultrasound in the lung. Ultrasound Med Biol 1993; 19:127-135.
9. Kondo T, Kodaira T, Kano E. Free radical formation induced by ultrasound and its effects on strand breakage in DNA of cultured FM3A cells. Free Radic Res Commun 1993; 19:S193-S200.
10. Ikeda Y, Handa M, Kawano K, et al. The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress. J Clin Invest 1991; 87:1234-1240.
11. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999; 340:115-126
12. Pollachik SL, Chandler WL, Mourad PD, Ollos RL, Crum LA. Activation, aggregation and adhesion of platelets exposed to high-intensity focused ultrasound. Ultrasound Med Biol 2001; 27:1567-1576.
13. Miller DL, Nyborg WL. Platelet aggregation induced by ultrasound under specialized conditions in vitro. Science 1979; 205:505-507.
14. Williams AR, Chater BV, Allen KA, Sherwood MR, Sanderson JH. Release of β-thromboglobulin from human platelets by therapeutic intensities of ultrasound. Br J Haematol 1978; 40:133-142.
15. Everbach EC, Makin IR, Francis CW, Meltzer RS. Effect of acoustic cavitation on platelets in the presence of an echo-contrast agent. Ultrasound Med Biol 1998; 24:129-136.
16. Leighton TG. The Acoustic Bubble. London, England: Academic Press; 1994.
17. Skalak R, Chien S. Handbook of Bioengineering. New York, NY: McGraw-Hill; 1987.
18. Charter BV, Williams AR. Platelet aggregation induced in vitro by therapeutic ultrasound. Thromb Haemost 1977; 38:640-651.
19. Williams AR, O'Brien WD, Coller JR. Exposure to ultrasound decreases the recalcification time of platelet rich plasma. Ultrasound Med Biol 1976; 2:113-118.
20. Berman CL, Yeo EL, Wencel-Drake JD, et al. A platelet alpha granule membrane protein that is associated with the plasma membrane after activation: characterization and subcellular localization of platelet activation-dependent granule-external membrane protein. J Clin Invest 1986; 78:130-137.
21. Nieuwenhuis HK, van Oosterhout JJG, Rozemuller E, van Iwaarden F, Sixma JJ. Studies with a monoclonal antibody against activated platelets: evidence that a secreted 53,000-molecular weight lysosomal-like granule protein is exposed on the surface of activated platelets in the circulation. Blood 1987; 70:838-845.
22. McEver RP, Martin MN. A monoclonal antibody to a membrane glycoprotein binds only to activated platelets. J Biol Chem 1984; 259:9799-9804.
23. Metzelaar MJ, Wijngaard PLJ, Peters PJ, Sixma JJ, Nieuwenhuis HK, Clevers HC. CD63 antigen: a novel lysosomal membrane glycoprotein, cloned by a screening procedure for intracellular antigens in eukaryotic cells. J Biol Chem 1991; 266:3239-3245.
24. Holmes MB, Sobel BE, Howard DB, Schneider DJ. Difference between activation thresholds for platelet P-selectin and glycoprotein IIb-IIIa expression and their clinical implications. Thromb Res 1999; 95:75-82.
25. Shattil SJ, Cunningham M, Hoxie JA. Detection of activated platelets in whole blood using activation dependent monoclonal antibodies and flow cytometry. Blood 1987; 70:307-315.
26. Schneider D, Tracy PB, Mann KG, Sobel BE. Differential effects of anticoagulations on the activation of platelets ex vivo. Circulation 1997; 96:2877-2883.
27. George JN, Pickett EB, Saucerman S, et al. Platelet surface glycoproteins: studies on resting and activated platelets and platelet membrane microparticles in normal subjects, and observation in patients during adult respiratory distress syndrome and cardiac surgery. J Clin Invest 1986; 78:340-348.
28. Knight CJ, Panesar M, Wright C, et al. Altered platelet function detected by flow cytometry: effect of coronary artery disease and age. Arterioscler Thromb Vasc Biol 1997; 17:2044-2053.
29. Rinder CS, Bohnert J, Rinder HM, Michell J, Ault K, Hillman R. Platelet activation and aggregation during cardiopulmonary bypass. Anesthesiology 1991; 75:388-393.
30. Miller DL, Williams AR. Bubble cycling as the explanation of the promotion of ultrasonic cavitation in a rotating tube exposure system. Ultrasound Med Biol 1989; 15:641-648.
31. Longo N, Elsas L. Human glucose transporters. Adv Pediatr 1998; 45:293-313.
32. James DC, Michael S, Christopher IC. GLUT-3 (brain-type) glucose transporter polypeptides in human blood platelets. Thromb Res 1995; 15:461-469.
33. Engerman RL, Kern TS. Experimental galactosemia produces diabetic-like retinopathy. Diabetes 1984; 33:97-100.
34. Takahashi Y, Wyman M, Ferris F III, Kador PF. Diabetes-like preproliferative retinal changes in galactose-fed dogs. Arch Ophthalmol 1992; 110:1295-1302.